Supreme Court of Canada limits Health Canada's ability to disclose commercially sensitive information
On February 3, 2012, the Supreme Court of Canada released a decision that limits Health Canada’s ability to disclose an innovator’s commercially sensitive pharmaceutical product information to competitors.
Popular articles from this firm
